Diet-derived microbial metabolites in health and disease

Nutrition Bulletin

Volumn 44, Issue 3, 2019, Pages 216-227

  Roager, H M ^a   Dragsted, L O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

diet; health; metabolites; metabolomics; microbial; microbiota

Indexed keywords

EID: 85070982184     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/nbu.12396     Document Type: Review

References (145)

1. Aarestrup J, Kyrø C, Knudsen KBE et al. (2013) Plasma enterolactone and incidence of endometrial cancer in a case–cohort study of Danish women. British Journal of Nutrition 109: 2269–75.
2. Acar E, Gürdeniz G, Khakimov B et al. (2019) Biomarkers of individual foods, and separation of diets using untargeted LC-MS-based plasma metabolomics in a randomized controlled trial. Molecular Nutrition & Food Research 63: 1800215.
3. Andersen MB, Rinnan Å, Manach C et al. (2014) Untargeted metabolomics as a screening tool for estimating compliance to a dietary pattern. Journal of Proteome Research 13: 1405–1418. https://doi.org/10.1021/pr400964s.
4. Arpaia N, Campbell C, Fan X et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451–5.
5. Axelson M, Sjövall J, Gustafsson BE et al. (1982) Origin of lignans in mammals and identification of a precursor from plants. Nature 298: 659–60.
6. Baxter NT, Schmidt AW, Venkataraman A et al. (2019) Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio 10: e02566-18.
7. van der Beek CM, Canfora EE, Lenaerts K et al. (2016) Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clinical Science 130: 2073–82.
8. Blaženović I, Kind T, Ji J et al. (2018) Software tools and approaches for compound identification of LC-MS/MS data in metabolomics. Metabolites 8: 31.
9. Brown AJ, Goldsworthy SM, Barnes AA et al. (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 278: 11312–9.
10. Canfora EE, van der Beek CM, Jocken JWE et al. (2017) Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. Scientific Reports 7: 2360.
11. Cerdá B, Periago P, Espín JC et al. (2005) Identification of urolithin A as a metabolite produced by human colon microflora from ellagic acid and related compounds. American Chemical Society 53: 5571–5576. https://doi.org/10.1021/JF050384I.
12. Chang PV, Hao L, Offermanns S et al. (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proceedings of the National Academy of Sciences 111: 2247–52.
13. Chen H, Nwe PK, Yang Y et al. (2019) A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell 177: 1217–1231. https://doi.org/10.1016/j.cell.2019.03.036.
14. Christensen L, Roager HM, Astrup A et al. (2018) Microbial enterotypes in personalized nutrition and obesity management. The American Journal of Clinical Nutrition 108: 645–51.
15. Cotillard A, Kennedy SP, Kong LC et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature 500: 585–8.
16. Cummings JH & Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. The Journal of Applied Bacteriology 70: 443–59.
17. Cummings JH, Pomare EW, Branch WJ et al. (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221–7.
18. Dalile B, Van Oudenhove L, Vervliet B et al. (2019) The role of short-chain fatty acids in microbiota–gut–brain communication. Nature Reviews Gastroenterology & Hepatology 16: 461–478. https://doi.org/10.1038/s41575-019-0157-3.
19. Dambrova M, Latkovskis G, Kuka J et al. (2016) Diabetes is associated with higher trimethylamine N-oxide plasma levels. Experimental and Clinical Endocrinology & Diabetes 124: 251–6.
20. David L, Maurice CF, Carmody RN et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559–63.
21. De Filippis F, Pellegrini N, Vannini L et al. (2016) High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65: 1812–21.
22. De Filippis F, Pasolli E, Tett A et al. (2019) Distinct genetic and functional traits of human intestinal Prevotella copri strains are associated with different habitual diets. Cell Host & Microbe 25: 444–453.e3.
23. Devlin AS, Marcobal A, Dodd D et al. (2016) Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host & Microbe 20: 709–15.
24. Draper CF, Vassallo I, Di Cara A et al. (2018) A 48-hour vegan diet challenge in healthy women and men induces a BRANCH-chain amino acid related, health associated, metabolic signature. Molecular Nutrition & Food Research 62: 1700703.
25. van Duynhoven J, Vaughan EE, Jacobs DM et al. (2011) Metabolic fate of polyphenols in the human superorganism. Proceedings of the National Academy of Sciences of the United States of America 108(Suppl): 4531–8.
26. Eeckhaut E, Struijs K, Possemiers S et al. (2008) Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. Journal of Agricultural and Food Chemistry 56: 4806–12.
27. van Faassen A, Hazen MJ, van den Brandt PA et al. (1993) Bile acids and pH values in total feces and in fecal water from habitually omnivorous and vegetarian subjects. The American Journal of Clinical Nutrition 58: 917–22.
28. Falony G, Joossens M, Vieira-Silva S et al. (2016) Population-level analysis of gut microbiome variation. Science 352: 560–4.
29. Fernández-Reina A, Urdiales JL & Sánchez-Jiménez F (2018) What we know and what we need to know about aromatic and cationic biogenic amines in the gastrointestinal tract. Foods 7: 145. https://doi.org/10.3390/foods7090145.
30. Furusawa Y, Obata Y, Fukuda S et al. (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446–50.
31. GBD 2017 Diet Collaborators (2019) Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 393: 1958–1972. https://doi.org/10.1016/S0140-6736(19)30041-8.
32. Geypens B, Claus D, Evenepoel P et al. (1997) Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 41: 70–6.
33. Giménez-Bastida JA, González-Sarrías A, Larrosa M et al. (2012) Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Molecular Nutrition & Food Research 56: 784–96.
34. Gratz SW, Hazim S, Richardson AJ et al. (2018) Dietary carbohydrate rather than protein intake drives colonic microbial fermentation during weight loss. European Journal of Nutrition 58: 1147–1158. https://doi.org/10.1007/s00394-018-1629-x.
35. Guérin A, Mody R, Fok B et al. (2014) Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Alimentary Pharmacology & Therapeutics 40: 83–92.
36. Guijas C, Montenegro-Burke JR, Warth B et al. (2018) Metabolomics activity screening for identifying metabolites that modulate phenotype. Nature Biotechnology 36: 316–20.
37. Halmos EP, Christophersen CT, Bird AR et al. (2015) Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 64: 93–100.
38. Hansen LBS, Roager HM, Søndertoft NB et al. (2018) A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults. Nature Communications 9: 4630.
39. Healey GR, Murphy R, Brough L et al. (2017) Interindividual variability in gut microbiota and host response to dietary interventions. Nutrition Reviews 75: 1059–80.
40. Heianza Y, Ma W, Manson JE et al. (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. Journal of the American Heart Association 6: 7. https://doi.org/10.1161/JAHA.116.004947.
41. Heinzmann SS, Merrifield CA, Rezzi S et al. (2012) Stability and robustness of human metabolic phenotypes in response to sequential food challenges. Journal of Proteome Research 11: 643–55.
42. Holmes E, Loo RL, Stamler J et al. (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396–400.
43. Hoyles L, Fernández-Real JM, Federici M et al. (2018) Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nature Medicine 24: 1070–80.
44. Huijbregts AW, Van Schaik A, Van Berge-Henegouwen GP et al. (1980) Serum lipids, biliary lipid composition, and bile acid metabolism in vegetarians as compared to normal controls. European Journal of Clinical Investigation 10: 443–9.
45. Hullar MAJ, Lancaster SM, Li F et al. (2015) Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States. Cancer Epidemiology, Biomarkers & Prevention 24: 546–54.
46. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207–14.
47. Husted AS, Trauelsen M, Rudenko O et al. (2017) GPCR-mediated signaling of metabolites. Cell Metabolism 25: 777–96.
48. Hylemon PB, Zhou H, Pandak WM et al. (2009) Bile acids as regulatory molecules. Journal of Lipid Research 50: 1509–20.
49. Istas G, Feliciano RP, Weber T et al. (2018) Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: a double-blind randomized controlled trial. Archives of Biochemistry and Biophysics 651: 43–51.
50. Johnsen NF, Hausner H, Olsen A et al. (2004) Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. The Journal of Nutrition 134: 2691–7.
51. Johnsen NF, Olsen A, Thomsen BL et al. (2010) Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women. Cancer Causes & Control 21: 153–62.
52. Johnson AJ, Vangay P, Al-Ghalith GA et al. (2019) Daily sampling reveals personalized diet-microbiome associations in humans. Cell Host & Microbe 25: 789–802.e5.
53. Khakimov B, Poulsen SK, Savorani F et al. (2016) New Nordic diet versus average Danish diet: a randomized controlled trial revealed healthy long-term effects of the new Nordic diet by GC-MS blood plasma metabolomics. Journal of Proteome Research 15: 1939–54.
54. Kikuchi K, Saigusa D, Kanemitsu Y et al. (2019) Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nature Communications 10: 1835.
55. Kilkkinen A, Pietinen P, Klaukka T et al. (2002) Use of oral antimicrobials decreases serum enterolactone concentration. American Journal of Epidemiology 155: 472–7.
56. Koeth RA, Wang Z, Levison SB et al. (2013) Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine 19: 576–585.
57. Koeth RA, Levison BS, Culley MK et al. (2014) γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metabolism 20: 799–812.
58. Koh A, De Vadder F, Kovatcheva-Datchary P et al. (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165: 1332–45.
59. Koh A, Molinaro A, Ståhlman M et al. (2018) Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175: 947–961.e17.
60. Korem T, Zeevi D, Zmora N et al. (2017) Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metabolism 25: 1243–1253.e5.
61. Krüger R, Merz B, Rist MJ et al. (2017) Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions. Molecular Nutrition & Food Research 61: 1700363.
62. Lamas B, Richard ML, Leducq V et al. (2016) CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nature Medicine 22: 598–605. https://doi.org/10.1038/nm.4102.
63. Landfald B, Valeur J, Berstad A et al. (2017) Microbial trimethylamine-N-oxide as a disease marker: something fishy? Microbial Ecology in Health and Disease 28: 1327309.
64. Lappi J, Salojärvi J, Kolehmainen M et al. (2013) Intake of whole-grain and fiber-rich rye bread versus refined wheat bread does not differentiate intestinal microbiota composition in Finnish adults with metabolic syndrome. The Journal of Nutrition 143: 648–655. https://doi.org/10.3945/jn.112.172668.1.
65. Le Chatelier E, Nielsen T, Qin J et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541–6.
66. Lewis SJ & Heaton KW (1997) Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41: 245–51.
67. Ley RE, Turnbaugh PJ, Klein S et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–3.
68. Lin CH, Lin JW, Liu YC et al. (2014) Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study. Parkinsonism & Related Disorders 20: 1371–5.
69. Lloyd-Price J, Mahurkar A, Rahnavard G et al. (2017) Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550: 61–6.
70. Louis P & Flint HJ (2017) Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology 19: 29–41.
71. Lozupone CA, Stombaugh JI, Gordon JI et al. (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220–30.
72. Lynch SV & Pedersen O (2016) The human intestinal microbiome in health and disease. The New England Journal of Medicine 375: 2369–79.
73. Macfarlane GT, Cummings JH, Macfarlane S et al. (1989) Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. The Journal of Applied Bacteriology 67: 520–7.
74. Macfarlane S, Quigley ME, Hopkins MJ et al. (1998) Polysaccharide degradation by human intestinal bacteria during growth under multi-substrate limiting conditions in a three-stage continuous culture system. FEMS Microbiology Ecology 26: 231–43.
75. Macia L, Tan J, Vieira AT et al. (2015) Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nature Communications 6: 6734.
76. Manach C, Scalbertet A, Morand C et al. (2004) Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition 79: 727–47.
77. Matsumoto M, Kibe R, Ooga T et al. (2012) Impact of intestinal microbiota on intestinal luminal metabolome. Scientific Reports 2: 233.
78. McDonald D, Hyde E, Debelius JW et al. (2018) American gut: an open platform for citizen science microbiome research. mSystems 3: e00031-18. https://doi.org/10.1128/mSystems.00031-18.
79. McNeil NI (1984) The contribution of the large intestine to energy supplies in man. The American Journal of Clinical Nutrition 39: 338–42.
80. de Mello VD, Lankinen MA, Lindström J et al. (2017a) Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes. Molecular Nutrition & Food Research 61: 1700019.
81. de Mello VD, Paananen J, Lindström J et al. (2017b) Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Scientific Reports 7: 46337.
82. Milder IEJ, Kuijsten A, Arts ICW et al. (2007) Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a dutch endoscopy-based population. The Journal of Nutrition 137: 1266–71.
83. Miller CA, Corbin KD, da Costa KA et al. (2014) Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. The American Journal of Clinical Nutrition 100: 778–86.
84. Natividad JM, Agus A, Planchais J et al. (2018) Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metabolism 28: 737–749. https://doi.org/10.1016/j.cmet.2018.07.001.
85. van Nierop FS, Scheltema MJ, Eggink HM et al. (2017) Clinical relevance of the bile acid receptor TGR5 in metabolism. The Lancet Diabetes & Endocrinology 5: 224–33.
86. Nøhr MK, Pedersen MH, Gille A et al. (2013) GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154: 3552–64.
87. Nyangale EP, Mottram DS & Gibson GR (2012) Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. Journal of Proteome Research 11: 5573–85.
88. O'Keefe SJD, Li JV, Lahti L et al. (2015) Fat, fibre and cancer risk in African Americans and rural Africans. Nature Communications 6: 6342.
89. Pallister T, Jackson MA, Martin TC et al. (2017) Hippurate as a metabolomic marker of gut microbiome diversity: modulation by diet and relationship to metabolic syndrome. Scientific Reports 7: 13670.
90. Pasolli E, Asnicar F, Manara S et al. (2019) Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell 176: 649–662.e20.
91. Pedersen HK, Gudmundsdottir V, Nielsen HB et al. (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535: 376–81.
92. Ridlon JM, Kang DJJ & Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research 47: 241–59.
93. Rienks J, Barbaresko J & Nöthlings U (2017) Association of polyphenol biomarkers with cardiovascular disease and mortality risk: a systematic review and meta-analysis of observational studies. Nutrients 9: 415.
94. Roager HM & Licht TR (2018) Microbial tryptophan catabolites in health and disease. Nature Communications 9: 3294.
95. Roager HM, Hansen LB, Bahl MI et al. (2016) Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nature Microbiology 1: 16093.
96. Roager HM, Vogt JK, Kristensen M et al. (2019) Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial. Gut 68: 83–93.
97. Romo-Vaquero M, Cortés-Martín A, Loria-Kohen V et al. (2019) Deciphering the human gut microbiome of urolithin metabotypes: association with enterotypes and potential cardiometabolic health implications. Molecular Nutrition & Food Research 63: 1800958.
98. Rosas HD, Doros G, Bhasin S et al. (2015) A systems-level “misunderstanding”: the plasma metabolome in Huntington's disease. Annals of Clinical and Translational Neurology 2: 756–68.
99. Rothhammer V, Mascanfroni ID, Bunse L et al. (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nature Medicine 22: 586–597. https://doi.org/10.1038/nm.4106.
100. Rothschild D, Weissbrod O, Barkan E et al. (2018) Environment dominates over host genetics in shaping human gut microbiota. Nature 555: 210–5.
101. Ryu D, Mouchiroud L, Andreux PA et al. (2016) Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature Medicine 22: 879–88.
102. Saha P, Yeoh BS, Singh R et al. (2016) Gut microbiota conversion of dietary ellagic acid into bioactive phytoceutical urolithin a inhibits heme peroxidases. PLoS ONE 11: e0156811.
103. Sakata T (2019) Pitfalls in short-chain fatty acid research: a methodological review. Animal Science Journal 90: 3–13.
104. Samuel BS, Shaito A, Motoike T et al. (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 105: 16767–72.
105. Sayin S, Wahlström A, Felin J et al. (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism 17: 225–35.
106. Scalbert A, Brennan L, Manach C et al. (2014) The food metabolome: a window over dietary exposure. The American Journal of Clinical Nutrition 99: 1286–308.
107. Schroeder BO & Bäckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nature Medicine 22: 1079–89.
108. Selma MV, González-Sarrías A, Salas-Salvadó J et al. (2018) The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: comparison between normoweight, overweight-obesity and metabolic syndrome. Clinical Nutrition 37: 897–905.
109. Shafi T, Meyer TW, Hostetter TH et al. (2015) Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. PLoS ONE 10: e0126048.
110. Singh R, Chandrashekharappa S, Bodduluri SR et al. (2019) Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nature Communications 10: 89.
111. Smith EA & Macfarlane GT (1996) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. The Journal of Applied Bacteriology 81: 288–302.
112. Smith PM, Howitt MR, Panikov N et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis. Science 341: 569–73.
113. Smits SA, Leach J, Sonnenburg ED et al. (2017) Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science 357: 802–6.
114. Spicer RA, Salek R & Steinbeck C (2017) A decade after the metabolomics standards initiative it's time for a revision. Scientific Data 4: 170138.
115. Staudacher HM, Lomer MCE, Farquharson FM et al. (2017) A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology 153: 936–47.
116. Stewart CJ, Ajami NJ, O'Brien JL et al. (2018) Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562: 583–8.
117. Sumner LW, Amberg A, Barrett D et al. (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3: 211–21.
118. Sun Q, Wedick NM, Pan A et al. (2014) Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care 37: 1287–95.
119. Sun M, Wu W, Chen L et al. (2018) Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nature Communications 9: 3555.
120. Tang WH, Wang Z, Levison BS et al. (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 368: 1575–84.
121. Tang WH, Wang Z, Kennedy DJ et al. (2015) Gut microbiota-dependent trimethylamine N-Oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circulation Research 116: 448–55.
122. Thomas C, Pellicciari R, Pruzanski M et al. (2008) Targeting bile-acid signalling for metabolic diseases. Nature Reviews Drug Discovery 7: 678–93.
123. Tolhurst G, Heffron H, Lam YS et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61: 364–71.
124. Tomás-Barberán FA, García-Villalba R, González-Sarrías A et al. (2014) Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. Journal of Agricultural and Food Chemistry 62: 6535–8.
125. Tuomainen M, Lindström J, Lehtonen M et al. (2018) Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals. Nutrition & Diabetes 8: 35.
126. Turnbaugh PJ, Ley RE, Mahowald MA et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–31.
127. Turnbaugh PJ, Hamady M, Yatsunenko T et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480–4.
128. Vandeputte D, Falony G, Vieira-Silva S et al. (2015) Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65: 57–62. https://doi.org/10.1136/gutjnl-2015-309618.
129. Vieira-Silva S, Falony G, Darzi Y et al. (2016) Species–function relationships shape ecological properties of the human gut microbiome. Nature Microbiology 1: 16088.
130. Vitaglione P, Mennella I, Ferracane R et al. (2014) Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber. American Journal of Clinical Nutrition 101: 251–61.
131. Von Engelhardt W, Rönnau K, Rechkemmer G et al. (1989) Absorption of short-chain fatty acids and their role in the hindgut of monogastric animals. Animal Feed Science and Technology 23: 43–53.
132. Wahlström A, Sayin SI, Marschall HU et al. (2016) Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metabolism 24: 41–50.
133. Walker AW, Duncan SH, MacWilliam Leitch EC et al. (2005) pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Applied and Environmental Microbiology 71: 3692–700.
134. Wang Z, Klipfell E, Bennett BJ et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57–63.
135. Wang M, Carver JJ, Phelan VV et al. (2016) Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nature Biotechnology 34: 828–37.
136. Wichmann A, Allahyar A, Greiner TU et al. (2013) Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host & Microbe 14: 582–90.
137. Wikoff WR, Anfora AT, Liu J et al. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 106: 3698–703.
138. Wu GD, Chen J, Hoffmann C et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, N.Y.) 334: 105–8.
139. Wu GD, Compher C, Chen EZ et al. (2014) Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut 65: 63–72. https://doi.org/10.1136/gutjnl-2014-308209.
140. Wu W, Sun M, Chen F et al. (2017) Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunology 10: 946–56.
141. Zeevi D, Korem T, Zmora N et al. (2015) Personalized nutrition by prediction of glycemic responses. Cell 163: 1079–94.
142. Zeisel SH, Mar MH, Howe JC et al. (2003) Concentrations of choline-containing compounds and betaine in common foods. The Journal of Nutrition 133: 1302–7.
143. Zhao Y, Chen F, Wu W et al. (2018) GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunology 11: 752–62.
144. Zhu W, Gregory JC, Org E et al. (2016) Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165: 111–24.
145. Zierer J, Jackson MA, Kastenmüller G et al. (2018) The fecal metabolome as a functional readout of the gut microbiome. Nature Genetics 50: 790–5.